Transcutaneous closure of chronic broncho-pleuro-cutaneous fistula by duct occluder device

Marwah, Vikas; Ravikumar, R; Rajput, Ashok Kumar; Singh, Amandeep

doi:10.4103/0970-2113.177440

Cited by 8 publications

(6 citation statements)

References 8 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Nonoperative factors include diabetes mellitus, hypoalbuminemia, cirrhosis, and steroid administration. When the patient is severely debilitated or life expectancy is limited, palliation can sometimes be provided by a surgically created pleurocutaneous tract to vent the pleural space on a permanent or temporary basis [ 10 ]. In the present case, due to his comorbidities-diabetes mellitus, and cirrhosis of the liver and to avoid the morbidity of major operations, conservative management was employed for fistula control.…”

Section: Discussionmentioning

confidence: 99%

Management of acquired bronchopleural fistula due to chemical pneumonia

2018

View full text Add to dashboard Cite

Bronchopleural fistula (BPF) is a sinus tract between the bronchus and the pleural space that may result from a necrotizing pneumonia/empyema (anaerobic, pyogenic, tuberculous, or fungal), lung neoplasms, and blunt and penetrating lung injuries or may occur as a complication of procedures such as lung biopsy, chest tube drainage, thoracocentesis, or radiation therapy. The diagnosis and management of BPF remain a major therapeutic challenge for clinicians, and the lesion is associated with significant morbidity and mortality. Here, we present a 70-year-old male with acquired BPF due to chemical pneumonitis caused by aspiration of kerosene who presented with the symptoms of fever, cough with expectoration, breathlessness and signs of tachycardia, tachypnea, diminished breath sounds, and crepitations. After a 3-week course of culture-sensitive antibiotics with β-lactam and β-lactamase inhibitors, open drainage of the empyema was done following which the patient showed symptomatic improvement and was discharged.

show abstract

Section: Discussionmentioning

confidence: 99%

Management of acquired bronchopleural fistula due to chemical pneumonia

2018

View full text Add to dashboard Cite

show abstract

“…Surgical repair of the fistula is the treatment of choice in such patients. However, the large intrathoracic granuloma, her poor general condition, and her chronic kidney disease hindered the surgical intervention [ 10 ].…”

Section: Case Discussionmentioning

confidence: 99%

Broncho-pleuro-cutaneous fistula and pneumothorax: Rare challenging complications of chest wall eumycetoma

Saad¹,

Fahal²

2017

PLoS Negl Trop Dis

View full text Add to dashboard Cite

“…Indications: (1) fistula diameter >5 mm; (2) the anatomy of the fistula is similar to ASD [10]; Contraindications: (1) fistula periphery has or is near the large vessel [11]; (2) the fistula is located at the bronchus below the pulmonary segment; (3) incomplete lung fissure or cribriform fistulas (many small fistulas) appears in the lung section after pulmonary wedge resection.…”

Section: Indications and Contraindicationsmentioning

confidence: 99%

Clinical Observation of Modified Implantation of ASD Closure Device to Treat BPFs

Zhang

Chen

et al. 2022

Concepts in Magnetic Resonance Part A

View full text Add to dashboard Cite

Objectives. The aim of the paper is to explore the clinical efficacy and prognosis of the modified implantation of atrial septal defect (ASD) closure device to treat bronchopleural fistulas (BPFs). Methods. This paper has reviewed the results of 13 BPF patients implanted with a modified ASD closure device in Shaw Hospital Affiliated with the Medical College of Zhejiang University from October 2018 to November 2021. Anesthesia was selected based on the patient’s condition. Different sizes of ASD closures were selected based on the characteristics of fistulas. The modified implantation of the ASD closure device was applied to treat BPFs. The closure effects, closure time, and Borg score were observed at 4 weeks, 8 weeks, and 12 weeks after the surgery. Results. All 13 BPF patients were successfully implanted with the ASD closure device, and the immediate clinical remission rate was 100%. Follow-up at 4 weeks after the surgery showed that 2 cases were automatically discharged within a few days and 4 cases had closed fistula at 1 day after the surgery; follow-up at 8 weeks after the surgery showed that 1 case with fistula closure was observed at 55 days after the surgery; follow-up at 12 weeks after the surgery showed that 1 case with fistula closure was observed at 82 days after the surgery. T/P values (T = 7.90, 5.99, 7.44, P < 0.05 ) of paired t-tests before surgery and 4 weeks, 8 weeks, and 12 weeks after the surgery were rated by the Borg scale. The data were statistically different, and the clinical symptoms improved significantly. As of publication, the follow-up at 12 weeks after the surgery showed that the clinical remission rate was 9/11, namely, 81.8%, 3 of 11 cases had relieved clinical symptoms but still needed continuous drainage, and 2 cases had fistula closure. The median time of thoracic extubation was 63 (3,120) days. No patients died from surgical complications or BPF recurrence during the prognosis and the follow-up period. Conclusions. The modified implantation method has a high success rate and clinical remission rate, quick and early fistula closure, and simple and noninvasive operation, without the need for a dedicated delivery sheath and rigid endoscopy. Moreover, it has accurate positioning, reliable closure efficiency, and prognosis, and can be completed under local anesthesia. This reduces the operation time, difficulty, and risks of anesthesia.

show abstract

Transcutaneous closure of chronic broncho-pleuro-cutaneous fistula by duct occluder device

Cited by 8 publications

References 8 publications

Management of acquired bronchopleural fistula due to chemical pneumonia

Management of acquired bronchopleural fistula due to chemical pneumonia

Broncho-pleuro-cutaneous fistula and pneumothorax: Rare challenging complications of chest wall eumycetoma

Clinical Observation of Modified Implantation of ASD Closure Device to Treat BPFs

Contact Info

Product

Resources

About